Immunovant, Inc.(IMVT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IMVT Immunovant, Inc.

盘前交易 05-17 05:32:45 EDT

31.48

+0.55

+1.78%

最高31.54	最低30.40	成交量46.56万
今开30.81	昨收30.93	日振幅3.69%
总市值45.74亿	流通市值20.23亿	总股本1.45亿
成交额1,458万	换手率0.72%	流通股本6,425万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IMVT","market":"US","secType":"STK","nameCN":"Immunovant, Inc.","latestPrice":31.48,"timestamp":1715889600000,"preClose":30.93,"halted":0,"volume":465565,"delay":0,"floatShares":64254551,"shares":145292970,"eps":-1.813274,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.55,"latestTime":"05-17 05:32:45 EDT","open":30.81,"high":31.54,"low":30.4,"amount":14578955.211795,"amplitude":0.036857,"askPrice":33,"askSize":1,"bidPrice":27.44,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.813274,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715952600000},"adr":0,"adjPreClose":31.48,"postHourTrading":{"tag":"盘后","latestPrice":31.48,"preClose":31.48,"latestTime":"17:09 EDT","volume":31002,"amount":975931.7,"timestamp":1715893784733},"volumeRatio":0.5535582995070997},"requestUrl":"/m/hq/s/IMVT/tweets","defaultTab":"tweets","newsList":[{"id":"2434858445","title":"Immunovant Inc   预计每股亏损43美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2434858445","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2434858445?lang=zh_cn&edition=full","pubTime":"2024-05-10 20:10","pubTimestamp":1715343043,"startTime":"0","endTime":"0","summary":"   * Immunovant Inc    预计在5月13日公布截至2024年3月31日的业绩时，季度收入将没有变化(预计)。*    * LSEG分析师对Immunovant公司的平均预期是每股亏损43美分。* 华尔街对 Immunovant Inc 的 12 个月目标价中位数为 51.00 美元，高于其上次收盘价 29.70 美元。5月10日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2428234115","title":"Immunovant, Inc.盘中异动 快速下跌5.00%报28.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428234115","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428234115?lang=zh_cn&edition=full","pubTime":"2024-04-17 22:18","pubTimestamp":1713363487,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日22时18分，Immunovant, Inc.股票出现异动，股价快速下跌5.00%。截至发稿，该股报28.88美元/股，成交量17.5682万股，换手率0.12%，振幅4.78%。Immunovant, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。Immunovant, Inc.公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417221808861e6bad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417221808861e6bad&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421025459","title":"BUZZ-竞争对手中外制药的数据不尽如人意，Immunovant 和 Argenx 的业绩上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2421025459","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2421025459?lang=zh_cn&edition=full","pubTime":"2024-03-22 00:04","pubTimestamp":1711037051,"startTime":"0","endTime":"0","summary":"    3月21日 - ** 在日本中外制药公司  报告了其自身免疫性疾病药物satralizumab的后期数据后，Immunovant  的股价上涨2.5%至32.36美元，在美国上市的Argenx  的股价上涨12.3%至401美元。** 券商 Stifel 表示，由于该药物之前的研究数据令人印象深刻，因此该数据一直是 ARGX 和 IMVT 的主要障碍。** ARGX公司的Vyvgrat已被批准用于治疗这种疾病，而IMVT公司的实验性疗法正处于后期研究阶段。** Viridian Therapeutics    和 Tourmaline Bio    的股价分别下跌了 38.8% 和 38.8%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2419607011","title":"Immunovant, Inc.盘中异动 早盘股价大跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419607011","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419607011?lang=zh_cn&edition=full","pubTime":"2024-03-14 21:59","pubTimestamp":1710424784,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日21时59分，Immunovant, Inc.股票出现异动，股价大幅下跌5.31%。截至发稿，该股报30.13美元/股，成交量10.7659万股，换手率0.07%，振幅5.28%。Immunovant, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。其相关个股中，知临集团、Revolution Medicines Inc C/Wts 17/12/2026 、Nutriband Inc C/Wts 涨幅较大，知临集团、Novabay Pharmaceuticals, Inc.、Gri Bio, Inc.较为活跃，换手率分别为325.33%、137.79%、67.12%，振幅较大的相关个股有知临集团、Nuvectis Pharma, Inc.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为73.90%、46.47%、41.94%。Immunovant, Inc.公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314215945791a7ceb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314215945791a7ceb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416057904","title":"Immunovant, Inc.盘中异动 急速下跌5.08%报35.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416057904","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416057904?lang=zh_cn&edition=full","pubTime":"2024-03-01 01:37","pubTimestamp":1709228265,"startTime":"0","endTime":"0","summary":"北京时间2024年03月01日01时37分，Immunovant, Inc.股票出现波动，股价快速下跌5.08%。截至发稿，该股报35.75美元/股，成交量30.8892万股，换手率0.21%，振幅6.73%。Immunovant, Inc.股票所在的生物技术行业中，整体跌幅为1.54%。其相关个股中，Enveric Biosciences, Inc.、Cingulate Inc C/Wts 10/12/2026 、Revance Therapeutics, Inc.涨幅较大，Enveric Biosciences, Inc.、Adial Pharmaceuticals, Inc、Revelation Biosciences, Inc.较为活跃，换手率分别为5805.57%、1569.54%、97.36%，振幅较大的相关个股有Carmell Corp C/Wts 12/07/2028 、Enveric Biosciences, Inc.、Ys Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为164.60%、160.05%、95.99%。Immunovant, Inc.公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403010137457a483791&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403010137457a483791&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2412491731","title":"美国研究综述-波尔、Couchbase、霍利","url":"https://stock-news.laohu8.com/highlight/detail?id=2412491731","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2412491731?lang=zh_cn&edition=full","pubTime":"2024-02-20 15:28","pubTimestamp":1708414083,"startTime":"0","endTime":"0","summary":"    路透社2月20日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Ball、Couchbase 和 Holley。* Couchbase Inc   ：巴克莱将其评级从 \"增持 \"下调至 \"等权重\"。* Couchbase Inc   ：巴克莱将目标价从26美元上调至29美元              * Digital Realty Trust Inc   ：摩根大通将目标价从125美元上调至140美元              * Holley Inc   ：摩根大通将目标价从6.5美元下调至5美元              * 霍利公司  ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2407351402","title":"Immunovant Inc   预计每股亏损43美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2407351402","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2407351402?lang=zh_cn&edition=full","pubTime":"2024-01-30 21:53","pubTimestamp":1706622819,"startTime":"0","endTime":"0","summary":"   * Immunovant Inc    预计在2月1日公布截至2023年12月31日的业绩时，季度收入将没有变化(预计)。*    * LSEG分析师对Immunovant公司的平均预期是每股亏损43美分。* 华尔街对 Immunovant Inc 的 12 个月目标价中位数为 51.00 美元，高于其上次收盘价 39.32 美元。1月30日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2401565660","title":"Immunovant Inc盘中异动 股价大涨5.04%报40.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2401565660","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2401565660?lang=zh_cn&edition=full","pubTime":"2024-01-05 23:00","pubTimestamp":1704466832,"startTime":"0","endTime":"0","summary":"北京时间2024年01月05日23时00分，Immunovant Inc股票出现波动，股价大幅上涨5.04%。截至发稿，该股报40.85美元/股，成交量18.6584万股，换手率0.13%，振幅5.68%。Immunovant Inc股票所在的生物技术行业中，整体跌幅为0.22%。其相关个股中，Dermata Therapeutics Inc、Polypid Ltd、Neximmune Inc涨幅较大，Dermata Therapeutics Inc、Neximmune Inc、Avenue Therapeutics Inc较为活跃，换手率分别为400.30%、125.32%、71.99%，振幅较大的相关个股有Engene Holdings Inc C/Wts 31/10/2028  Cl A、Revolution Medicines Inc C/Wts  、Neximmune Inc，振幅分别为49.53%、40.68%、37.63%。Immunovant Inc公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401052300327a38c430&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401052300327a38c430&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2394408832","title":"Immunovant Inc盘中异动 早盘快速拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2394408832","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2394408832?lang=zh_cn&edition=full","pubTime":"2023-12-26 23:42","pubTimestamp":1703605323,"startTime":"0","endTime":"0","summary":"北京时间2023年12月26日23时42分，Immunovant Inc股票出现异动，股价大幅上涨5.03%。截至发稿，该股报43.57美元/股，成交量24.3075万股，换手率0.17%，振幅3.81%。Immunovant Inc股票所在的生物技术行业中，整体涨幅为0.27%。其相关个股中，Rayzebio Inc、Apollomics Inc C/Wts 01/04/2028 、亘喜生物涨幅较大，60 Degrees Pharmaceuticals Inc、Brainstrom Cell Therapeutics、Onconetix Inc较为活跃，换手率分别为225.42%、37.26%、17.02%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Celularity Inc C/Wts 16/07/2026 、60 Degrees Pharmaceuticals Inc，振幅分别为74.00%、62.56%、34.38%。Immunovant Inc公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231226234203861c6d97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231226234203861c6d97&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2393134415","title":"Immunovant Inc盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2393134415","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2393134415?lang=zh_cn&edition=full","pubTime":"2023-12-22 23:43","pubTimestamp":1703259821,"startTime":"0","endTime":"0","summary":"北京时间2023年12月22日23时43分，Immunovant Inc股票出现波动，股价快速上涨5.04%。截至发稿，该股报41.07美元/股，成交量38.5819万股，换手率0.27%，振幅4.83%。Immunovant Inc股票所在的生物技术行业中，整体涨幅为1.54%。其相关个股中，Karuna Therapeutics Inc、Puretech Health Plc、Atara Biotherapeutics Inc涨幅较大，Panbela Therapeutics Inc、Senti Biosciences Inc、Aditxt Inc较为活跃，换手率分别为64.86%、53.29%、18.49%，振幅较大的相关个股有Panbela Therapeutics Inc、Ocean Biomedical Inc C/Wts 14/02/2028 、Renovorx Inc，振幅分别为30.82%、30.77%、25.89%。Immunovant Inc公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023122223434187e61526&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023122223434187e61526&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2392194064","title":"Immunovant Inc盘中异动 早盘股价大跌13.11%报36.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2392194064","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2392194064?lang=zh_cn&edition=full","pubTime":"2023-12-20 22:31","pubTimestamp":1703082686,"startTime":"0","endTime":"0","summary":"北京时间2023年12月20日22时31分，Immunovant Inc股票出现波动，股价大幅跳水13.11%。截至发稿，该股报36.07美元/股，成交量75.5474万股，换手率0.52%，振幅3.49%。Immunovant Inc股票所在的生物技术行业中，整体跌幅为0.92%。其相关个股中，Biophytis、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Passage Bio Inc涨幅较大，Tracon Pharmaceuticals Inc、Panbela Therapeutics Inc、Bluebird Bio Inc较为活跃，换手率分别为66.13%、43.15%、40.10%，振幅较大的相关个股有Better Therapeutics Inc、Abivax、Adaptimmune Therapeutics Plc，振幅分别为14.92%、11.54%、8.13%。Immunovant Inc公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231220223126875c691f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231220223126875c691f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2392196253","title":"更新 1-药物研究失败，Argenx 市值缩水 63 亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2392196253","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2392196253?lang=zh_cn&edition=full","pubTime":"2023-12-20 21:18","pubTimestamp":1703078283,"startTime":"0","endTime":"0","summary":"截至格林尼治标准时间12时35分，该公司股价下跌了23.8%，有望从公司市值中抹去约58亿欧元。试验失败后 ，竞争对手Immunovant   的股价下跌了约11%，至37美元。这种药物也被称为依加替莫德，最近 未能达到   另一项研究的主要和次要目标，该研究是对一种名为免疫性血小板减少症的血液病患者进行测试 。\"在连续两次三期研究失败后，现在的问题是 argenx 和 efgartigimod 下一步该怎么办？","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2390378089","title":"Immunovant Inc盘中异动 股价大涨5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2390378089","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2390378089?lang=zh_cn&edition=full","pubTime":"2023-12-12 22:34","pubTimestamp":1702391685,"startTime":"0","endTime":"0","summary":"北京时间2023年12月12日22时34分，Immunovant Inc股票出现波动，股价快速上涨5.40%。截至发稿，该股报41.93美元/股，成交量30.5895万股，换手率0.21%，振幅5.99%。Immunovant Inc股票所在的生物技术行业中，整体跌幅为0.06%。其相关个股中，C4 Therapeutics Inc、Candel Therapeutics Inc、Icosavax Inc涨幅较大，C4 Therapeutics Inc、Candel Therapeutics Inc、Altamira Therapeutics Ltd较为活跃，换手率分别为59.13%、38.09%、22.26%，振幅较大的相关个股有Candel Therapeutics Inc、Elevai Labs Inc、Pasithea Therapeutics Corp，振幅分别为18.42%、16.22%、13.11%。Immunovant Inc公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231212223445874f8ae5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231212223445874f8ae5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2387437473","title":"Immunovant Inc盘中异动 早盘急速上涨5.10%报37.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2387437473","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2387437473?lang=zh_cn&edition=full","pubTime":"2023-11-29 23:29","pubTimestamp":1701271773,"startTime":"0","endTime":"0","summary":"北京时间2023年11月29日23时29分，Immunovant Inc股票出现波动，股价急速上涨5.10%。截至发稿，该股报37.85美元/股，成交量45.9706万股，换手率0.32%，振幅4.28%。Immunovant Inc股票所在的生物技术行业中，整体涨幅为0.60%。Immunovant Inc公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202311292329338476476d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202311292329338476476d&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immunovant.com","stockEarnings":[{"period":"1week","weight":0.0599},{"period":"1month","weight":0.0355},{"period":"3month","weight":-0.1522},{"period":"6month","weight":-0.0692},{"period":"1year","weight":0.4905},{"period":"ytd","weight":-0.2528}],"compareEarnings":[{"period":"1week","weight":0.0164},{"period":"1month","weight":0.05},{"period":"3month","weight":0.0584},{"period":"6month","weight":0.1728},{"period":"1year","weight":0.2732},{"period":"ytd","weight":0.1123}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Immunovant, Inc.于2018年12月6日在特拉华州注册成立,是一家临床阶段生物制药公司，专注于为自身免疫性疾病患者提供正常生活。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.094855},{"month":2,"riseRate":0,"avgChangeRate":-0.169332},{"month":3,"riseRate":0.2,"avgChangeRate":-0.041053},{"month":4,"riseRate":0.4,"avgChangeRate":-0.020694},{"month":5,"riseRate":0.6,"avgChangeRate":0.143617},{"month":6,"riseRate":0,"avgChangeRate":-0.132777},{"month":7,"riseRate":0.4,"avgChangeRate":0.035401},{"month":8,"riseRate":0.6,"avgChangeRate":0.117177},{"month":9,"riseRate":1,"avgChangeRate":0.165149},{"month":10,"riseRate":0.6,"avgChangeRate":0.20936},{"month":11,"riseRate":0.8,"avgChangeRate":0.09369},{"month":12,"riseRate":0.8,"avgChangeRate":0.198952}],"exchange":"NASDAQ","name":"Immunovant, Inc.","nameEN":"Immunovant, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immunovant, Inc.(IMVT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Immunovant, Inc.(IMVT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Immunovant, Inc.,IMVT,Immunovant, Inc.股票,Immunovant, Inc.股票老虎,Immunovant, Inc.股票老虎国际,Immunovant, Inc.行情,Immunovant, Inc.股票行情,Immunovant, Inc.股价,Immunovant, Inc.股市,Immunovant, Inc.股票价格,Immunovant, Inc.股票交易,Immunovant, Inc.股票购买,Immunovant, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immunovant, Inc.(IMVT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Immunovant, Inc.(IMVT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}